5
Beije, N., Kraan, J., Taal, W., van der Holt, B., Oosterkamp, H. M., Walenkamp, A. M., Beerepoot, L., Hanse, M., van Linde, M. E., Otten, A., Vernhout, R. M., de Vos, F. Y. F., Gratama, J. W., Sleijfer, S., van den Bent, M. J.
Veröffentlicht in: Beije , N , Kraan , J , Taal , W , van der Holt , B , Oosterkamp , H M , Walenkamp , A M , Beerepoot , L , Hanse , M , van Linde , M E , Otten , A , Vernhout , R M , de Vos , F Y F , Gratama , J W , Sleijfer , S & van den Bent , M J 2015 , ' Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial ' , British Jounal of Cancer , vol. 113 , no. 2 , pp. 226-231 . https://doi.org/10.1038/bjc.2015.191;
2015
8
Hamer, Philip C. De Witt, Ho, Vincent K. Y., Zwinderman, Aeilko H., Ackermans, Linda, Ardon, Hilko, Boomstra, Sytske, Bouwknegt, Wim, van den Brink, Wimar A., Dirven, Clemens M., van der Gaag, Niels A., van der Veer, Olivier, Idema, Albert J. S., Kloet, Alfred, Koopmans, Jan, ter Laan, Mark, Verstegen, Marco J. T., Wagemakers, Michiel, Robe, Pierre A. J. T.
Veröffentlicht in: Dutch Soc Neurosurg , Hamer , P C D W , Ho , V K Y , Zwinderman , A H , Ackermans , L , Ardon , H , Boomstra , S , Bouwknegt , W , van den Brink , W A , Dirven , C M , van der Gaag , N A , van der Veer , O , Idema , A J S , Kloet , A , Koopmans , J , ter Laan , M , Verstegen , M J T , Wagemakers , M & Robe , P A J T 2019 , ' Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery ' , JOURNAL OF NEURO-ONCOLOGY , vol. 144 , no. 2 , pp. 313-323 . https://doi.org/10.1007/s11060-019-03229-5;
2019